Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era.

[1]  Pekka Raatikainen,et al.  Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. , 2003, Journal of the American College of Cardiology.

[2]  R. Berger,et al.  B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure , 2002, Circulation.

[3]  B. Lindahl,et al.  Usefulness of plasma N-terminal proatrial natriuretic peptide (proANP) as an early predictor of outcome in unstable angina pectoris or non-ST-elevation acute myocardial infarction. , 2002, The American journal of cardiology.

[4]  Takanori Ikeda,et al.  T-wave alternans as a predictor for sudden cardiac death after myocardial infarction. , 2002, The American journal of cardiology.

[5]  M. Farrer,et al.  Left ventricular remodelling and brain natriuretic peptide after first myocardial infarction , 2001, Heart.

[6]  H. Huikuri,et al.  Sudden death due to cardiac arrhythmias. , 2001, The New England journal of medicine.

[7]  M. Sabatine,et al.  The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. , 2001, The New England journal of medicine.

[8]  H. Huikuri,et al.  Prognostic Significance of Risk Stratifiers of Mortality, Including T Wave Alternans, After Acute Myocardial Infarction: Results of a Prospective Follow‐Up Study , 2001, Journal of cardiovascular electrophysiology.

[9]  D. Barnett,et al.  Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction. , 2000, European heart journal.

[10]  J. Burnett,et al.  Natriuretic peptides in the pathophysiology of congestive heart failure , 2000, Current cardiology reports.

[11]  T. Ikeda,et al.  Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. , 2000, Journal of the American College of Cardiology.

[12]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[13]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[14]  S. Gottlieb,et al.  Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. , 1998, The New England journal of medicine.

[15]  C. Frampton,et al.  Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. , 1998, Circulation.

[16]  M. Redfield,et al.  Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. , 1998, American journal of physiology. Heart and circulatory physiology.

[17]  J. Bigger,et al.  Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction , 1998, The Lancet.

[18]  H. Elming,et al.  Use of Left Ventricular Ejection Fraction or Wall‐Motion Score Index in Predicting Arrhythmic Death in Patients Following an Acute Myocardial Infarction , 1997, Pacing and clinical electrophysiology : PACE.

[19]  C. Lang,et al.  Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. , 1996, The American journal of cardiology.

[20]  F Sachs,et al.  Stretch-induced voltage changes in the isolated beating heart: importance of the timing of stretch and implications for stretch-activated ion channels. , 1996, Cardiovascular research.

[21]  N. Arakawa,et al.  Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. , 1996, Journal of the American College of Cardiology.

[22]  R. T. Lie,et al.  Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. , 1996, Circulation.

[23]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[24]  P. Denes,et al.  Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arryhthmic events in the postinfarction period , 1995 .

[25]  K. Kugiyama,et al.  Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure , 1994, Circulation.

[26]  G. Lamas,et al.  N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. , 1994, Circulation.

[27]  A. Struthers,et al.  Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction , 1993, The Lancet.

[28]  P. Koistinen,et al.  Effect of physical exercise in hypobaric conditions on atrial natriuretic peptide secretion. , 1992, The American journal of physiology.

[29]  T. Pindborg,et al.  Plasma concentration of atrial natriuretic peptide at admission and risk of cardiac death in patients with acute myocardial infarction , 1992, British heart journal.

[30]  P. Kowey,et al.  Electrophysiological Effects of Left Ventricular Hypertrophy: Effect of Calcium and Potassium Channel Blockade , 1991, Circulation.

[31]  K. Inouye,et al.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. , 1991, The Journal of clinical investigation.

[32]  J. Berning,et al.  Early estimation of risk by echocardiographic determination of wall motion index in an unselected population with acute myocardial infarction. , 1990, The American journal of cardiology.

[33]  L. Hondeghem,et al.  Stretch-induced arrhythmias in the isolated canine ventricle. Evidence for the importance of mechanoelectrical feedback. , 1990, Circulation.

[34]  M. Reiter,et al.  Electrophysiological Effects of Acute Ventricular Dilatation in the Isolated Rabbit Heart , 1988, Circulation research.

[35]  N. Ling,et al.  Atrial natriuretic polypeptides (ANP): rat atria store high molecular weight precursor but secrete processed peptides of 25-35 amino acids. , 1985, Biochemical and biophysical research communications.

[36]  J P Miller,et al.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. , 1984, Circulation.

[37]  J. Fleiss,et al.  Risk stratification and survival after myocardial infarction. , 1983, The New England journal of medicine.

[38]  A. Tamhane.  Multiple comparisons in model i one-way anova with unequal variances , 1977 .

[39]  Morton B. Brown,et al.  Robust Tests for the Equality of Variances , 1974 .

[40]  W. Hoeffding,et al.  Contributions to Probability and Statistics: Essays in Honor of Harold Hotelling , 1961 .